US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
ES2223536T3
(es)
*
|
1999-06-15 |
2005-03-01 |
Bristol-Myers Squibb Pharma Company |
Gamma-carbolinas condensadas con heterociclos sustituidas.
|
AR034264A1
(es)
*
|
2000-09-20 |
2004-02-18 |
Upjohn Co |
Derivados azepino(4,5-b)indol sustituidos y composiciones farmaceuticas
|
US6858604B2
(en)
|
2000-11-03 |
2005-02-22 |
Wyeth |
Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
US6777407B2
(en)
|
2000-11-03 |
2004-08-17 |
Wyeth |
Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
US6759405B2
(en)
|
2000-11-03 |
2004-07-06 |
Wyeth |
Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
DK1337518T3
(da)
|
2000-11-20 |
2009-10-19 |
Biovitrum Ab Publ |
Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
EP1343791A2
(en)
*
|
2000-12-20 |
2003-09-17 |
Bristol-Myers Squibb Company |
Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
KR100626255B1
(ko)
*
|
2001-06-01 |
2006-09-21 |
알콘, 인코퍼레이티드 |
피라노인다졸 및 녹내장의 치료를 위한 그의 용도
|
CA2447156A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Novel fused indazoles and indoles and their use for the treatment of glaucoma
|
WO2002098400A1
(en)
*
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Novel arylaminopropane analogues and their use for the treatment of glaucoma
|
US20030060462A1
(en)
*
|
2001-08-06 |
2003-03-27 |
Hoffman Robert L. |
Therapeutic compounds
|
US6720316B2
(en)
|
2001-08-06 |
2004-04-13 |
Pharmacia & Upjohn Company |
Therapeutic 5-HT ligand compounds
|
WO2003024976A2
(en)
*
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
EP1436294A1
(en)
|
2001-10-18 |
2004-07-14 |
PHARMACIA & UPJOHN COMPANY |
Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
|
TWI312781B
(en)
|
2002-04-25 |
2009-08-01 |
|
[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307682A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307540A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
|
ATE454383T1
(de)
|
2002-06-19 |
2010-01-15 |
Biovitrum Ab Publ |
Neue verbindungen, deren verwendung und herstellung
|
US6958420B2
(en)
*
|
2002-07-19 |
2005-10-25 |
Board Of Trustees Of Michigan State University |
Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof
|
AU2003262931B2
(en)
*
|
2002-08-30 |
2008-06-26 |
Alcon, Inc. |
Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
|
BR0316775A
(pt)
|
2002-12-13 |
2005-11-01 |
Alcon Inc |
Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
|
ATE509929T1
(de)
*
|
2002-12-19 |
2011-06-15 |
Bristol Myers Squibb Co |
Substituierte tricyclische gamma-carbolineals serotonin-rezeptor-agonisten und antagonisten
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
US7728155B2
(en)
|
2003-10-24 |
2010-06-01 |
Wyeth Llc |
Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
US6989445B2
(en)
|
2003-12-15 |
2006-01-24 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
KR20120073287A
(ko)
|
2004-03-15 |
2012-07-04 |
피티씨 테라퓨틱스, 인크. |
혈관형성을 억제하는데 유용한 카르볼린 유도체
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
EP1758866A1
(en)
|
2004-06-18 |
2007-03-07 |
Wyeth |
Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
|
JP5173190B2
(ja)
|
2004-08-25 |
2013-03-27 |
武田薬品工業株式会社 |
腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
|
GT200500317A
(es)
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
US7425572B2
(en)
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
AR054849A1
(es)
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
CN101404882A
(zh)
*
|
2006-01-19 |
2009-04-08 |
阿特西斯公司 |
作为5-羟色胺5-HT2c受体配体的噻吩基和吡咯基氮杂类及其用途
|
EP2727585A1
(en)
|
2006-05-16 |
2014-05-07 |
Takeda Pharmaceutical Company Limited |
In-vivo screening method
|
CA2666193A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use
|
EP3663294A1
(en)
|
2007-03-12 |
2020-06-10 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
CA3089569C
(en)
|
2007-06-04 |
2023-12-05 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US20100266504A1
(en)
|
2007-11-15 |
2010-10-21 |
Takahiro Matsumoto |
Condensed pyridine derivative and use thereof
|
MX2010007430A
(es)
|
2008-01-11 |
2010-12-21 |
Albany Molecular Res Inc |
Piridoindoles (1-azinona)-sustituidos como antagonistas de la hormona de concentracion melanina humana.
|
ES2530090T3
(es)
|
2008-03-12 |
2015-02-26 |
Intra-Cellular Therapies, Inc. |
Sólido de gamma-carbolinas fusionadas con heterociclo sustituido
|
KR102184038B1
(ko)
|
2008-05-27 |
2020-11-27 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
수면 장애 및 다른 장애를 치료하기 위한 방법 및 조성물
|
AU2015218433B2
(en)
*
|
2008-05-27 |
2017-07-27 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
EP2310372B1
(en)
|
2008-07-09 |
2012-05-23 |
Sanofi |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
CA2737031A1
(en)
*
|
2008-09-29 |
2010-04-01 |
Abbott Laboratories |
Indole and indoline derivatives and methods of use thereof
|
US9625475B2
(en)
*
|
2008-09-29 |
2017-04-18 |
Abbvie Inc. |
Indole and indoline derivatives and methods of use thereof
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
EP2448585B1
(en)
*
|
2009-07-01 |
2014-01-01 |
Albany Molecular Research, Inc. |
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
|
WO2011003021A1
(en)
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
US8618299B2
(en)
*
|
2009-07-01 |
2013-12-31 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
|
US8629158B2
(en)
*
|
2009-07-01 |
2014-01-14 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
|
BR112012000788A2
(pt)
|
2009-07-14 |
2016-02-23 |
Albany Molecular Res Inc |
moduladores do receptor 5-ht3, métodos para preparar e uso dos mesmos
|
EP2470552B1
(en)
|
2009-08-26 |
2013-11-13 |
Sanofi |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
WO2011071136A1
(ja)
|
2009-12-11 |
2011-06-16 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
US9040519B2
(en)
|
2010-02-18 |
2015-05-26 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
WO2011103460A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]ondole derivatives and methods of use
|
WO2011103433A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
|
MX339805B
(es)
|
2010-04-22 |
2016-06-10 |
Intra-Cellular Therapies Inc |
Compuestos organicos.
|
WO2012030953A1
(en)
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
WO2012088124A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
|
US8697700B2
(en)
|
2010-12-21 |
2014-04-15 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
|
WO2012099952A2
(en)
|
2011-01-19 |
2012-07-26 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
US20140303144A1
(en)
|
2011-02-18 |
2014-10-09 |
Medivation Technologies, Inc. |
Compounds and methods of treating hypertension
|
CA2828346C
(en)
|
2011-03-01 |
2021-01-26 |
Synergy Pharmaceuticals Inc. |
Process of preparing guanylate cyclase c agonists
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8809324B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683701B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
US9428506B2
(en)
*
|
2012-04-14 |
2016-08-30 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
EP2981266B1
(en)
*
|
2013-03-04 |
2018-01-03 |
Daya CNS LLC |
Pentacyclic pyridoindolobenz[b,d]azepine derivatives and uses thereof
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
JP6606491B2
(ja)
|
2013-06-05 |
2019-11-13 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
HUE056496T2
(hu)
|
2013-12-03 |
2022-02-28 |
Intra Cellular Therapies Inc |
Eljárás skizofrénia reziduális szimptómáinak kezelésére
|
MX365969B
(es)
|
2014-04-04 |
2019-06-21 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3286172B1
(en)
|
2015-04-23 |
2019-06-12 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
AU2017211791B2
(en)
|
2016-01-26 |
2022-01-06 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
MX2018011676A
(es)
|
2016-03-25 |
2018-12-19 |
Intra Cellular Therapies Inc |
Compuestos organicos.
|
EP3436016B1
(en)
*
|
2016-03-28 |
2022-04-27 |
Intra-Cellular Therapies, Inc. |
Novel co-crystals
|
JP2019513143A
(ja)
*
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規塩類および結晶
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
US10517849B2
(en)
|
2016-10-26 |
2019-12-31 |
Constellation Pharmaceuticals, Inc. |
LSD1 inhibitors and medical uses thereof
|
WO2018106916A1
(en)
*
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
WO2018126140A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2018126143A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
MX2021013640A
(es)
|
2017-03-24 |
2022-08-31 |
Intra Cellular Therapies Inc |
Composiciones novedosas y metodos.
|
EP3609501A4
(en)
|
2017-04-10 |
2020-08-19 |
Dr. Reddy's Laboratories Limited |
AMORPHIC FORM AND SOLID DISPERSIONS OF LUMATEPERONE P-TOSYLATE
|
US11376249B2
(en)
|
2017-07-26 |
2022-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
US10513515B2
(en)
|
2017-08-25 |
2019-12-24 |
Biotheryx, Inc. |
Ether compounds and uses thereof
|
US11440911B2
(en)
|
2017-09-26 |
2022-09-13 |
Intra-Cellular Therapies, Inc. |
Salts and crystals
|
WO2019102240A1
(en)
*
|
2017-11-27 |
2019-05-31 |
Egis Gyógyszergyár Zrt. |
Method for the manufacture of lumateperone and its salts
|
US20210052600A1
(en)
|
2017-12-27 |
2021-02-25 |
Takeda Pharmaceutical Company Limited |
Therapeutic agents for stress urinary incontinence and incotinence of feces
|
CA3094949A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
CN112585690A
(zh)
|
2018-06-21 |
2021-03-30 |
阿奎斯蒂弗医疗股份有限公司 |
用于制作含有药物活性物质的个性化个体单位剂量的系统和方法
|
CN109100437A
(zh)
*
|
2018-07-22 |
2018-12-28 |
邯郸学院 |
仲胺类抗抑郁药物的质谱检测方法
|
CA3106239A1
(en)
|
2018-07-27 |
2020-01-30 |
Biotheryx, Inc. |
Bifunctional compounds as cdk modulators
|
EP3843739A4
(en)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NEW METHODS
|
US11957791B2
(en)
|
2018-08-31 |
2024-04-16 |
Intra-Cellular Therapies, Inc. |
Methods
|
BR112021004053A2
(pt)
|
2018-09-07 |
2021-05-25 |
Aquestive Therapeutics, Inc. |
composições de filme oral e formas de dosagem tendo perfis de dissolução de ativo precisos
|
US20220024924A1
(en)
|
2018-11-27 |
2022-01-27 |
Teva Czech Industries S.R.O |
Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof
|
WO2020131911A1
(en)
*
|
2018-12-17 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
BR112021011792A2
(pt)
*
|
2018-12-17 |
2021-08-31 |
Intra-Cellular Therapies, Inc. |
Composto orgânico
|
CA3121631A1
(en)
*
|
2018-12-17 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
WO2020132474A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
EP3914235A4
(en)
*
|
2019-01-23 |
2022-09-07 |
Intra-Cellular Therapies, Inc. |
ADDICTION TREATMENT METHODS
|
EP3931189A4
(en)
|
2019-02-27 |
2022-11-30 |
The Regents Of The University Of California |
AZEPINO-INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS
|
EP3946345A4
(en)
*
|
2019-04-04 |
2023-01-04 |
Intra-Cellular Therapies, Inc. |
NEUROPATHIC PAIN TREATMENT METHODS
|
MX2022000143A
(es)
|
2019-07-07 |
2022-02-17 |
Intra Cellular Therapies Inc |
Metodos novedosos.
|
WO2021087359A1
(en)
|
2019-11-01 |
2021-05-06 |
Aquestive Therapeutics, Inc. |
Prodrug compositions and methods of treatment
|
KR20220126287A
(ko)
|
2019-11-14 |
2022-09-15 |
어퀘스티브 테라퓨틱스, 아이엔씨. |
멀티모달 조성물 및 치료 방법
|
WO2021119334A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
US11897930B2
(en)
|
2020-04-28 |
2024-02-13 |
Anwita Biosciences, Inc. |
Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
|
WO2022073470A1
(zh)
*
|
2020-10-09 |
2022-04-14 |
上海枢境生物科技有限公司 |
杂环取代的稠合γ-咔啉类衍生物、其制备方法、中间体及应用
|
CN112062767B
(zh)
*
|
2020-10-20 |
2022-03-11 |
杭州科巢生物科技有限公司 |
一种卢美哌隆的制备方法及其中间体
|
JP2024505429A
(ja)
|
2021-01-15 |
2024-02-06 |
アクエスティブ セラピューティクス インコーポレイテッド |
プロドラッグ組成物及び治療の方法
|
CA3210706A1
(en)
|
2021-03-09 |
2022-09-15 |
Alexander Mark Schobel |
Dosage forms having equivalent biocomparable profiles
|
CN116444520A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海科技大学 |
并环哌啶类化合物及其制备方法和用途
|
CN114456149A
(zh)
*
|
2022-02-24 |
2022-05-10 |
中国科学技术大学 |
一种多巴胺drd2受体拮抗剂及其用途
|
WO2023178111A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023178113A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US20230372336A1
(en)
|
2022-05-18 |
2023-11-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|